Pacira | PCRX - Stock


Pacira reported $150.37M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Assertio Holdings USD 24.76M 8.12M Sep/2025
Astellas Pharma JPY 297.26B 9.92B Mar/2025
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Cara Therapeutics USD 900K 0 Mar/2025
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
J&J USD 14.58B 392M Mar/2026
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Omeros USD 712K 266K Sep/2021
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Xeris Pharmaceuticals USD 74.23M 5.56M Mar/2026
Zoetis USD 2.55B 120M Mar/2026